Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

42 questions · 43 findings · 5 reviews · Stroke

No studies found 11 · 25.6%GRADE not reported 0 · 0%Very low 18 · 41.9%Low 11 · 25.6%Moderate 3 · 7%High 0 · 0%

Summary of findings table ‐ Recombinant activated factor VII vs placebo/open control

Intracerebral haemorrhage expansion by 24 hours · adults with acute spontaneous intracerebral haemorrhage

Summary of findings table ‐ Recombinant activated factor VII showed no clear difference in intracerebral haemorrhage expansion by 24 hours compared with placebo/open control (low certainty).

1 finding from 1 review

Summary of findings table ‐ Recombinant activated factor VII vs placebo/open control

All serious adverse events · adults with acute spontaneous intracerebral haemorrhage

It is very uncertain whether summary of findings table ‐ Recombinant activated factor VII changes all serious adverse events compared with placebo/open control (very low certainty).

1 finding from 1 review

Summary of findings table ‐ Recombinant activated factor VII vs placebo/open control

Death from any cause · adults with acute spontaneous intracerebral haemorrhage

Summary of findings table ‐ Recombinant activated factor VII showed no clear difference in death from any cause compared with placebo/open control (moderate certainty).

1 finding from 1 review

Summary of findings: Assessment/screening interventions vs control

Functional ability · stroke survivors with visual field defects

It is very uncertain whether summary of findings: Assessment/screening interventions changes functional ability in activities of daily living (FIM) After… compared with control (very low certainty).

1 finding from 1 review

Summary of findings table ‐ Starting short‐term prophylactic dose anticoagulation vs avoiding anticoagulation

Death · survivors of stroke due to intracerebral haemorrhage

It is very uncertain whether summary of findings table ‐ Starting short‐term prophylactic dose… changes death compared with avoiding anticoagulation (very low certainty).

1 finding from 1 review

Summary of findings table ‐ Starting short‐term prophylactic dose anticoagulation vs avoiding anticoagulation

Venous thromboembolism · survivors of stroke due to intracerebral haemorrhage

It is very uncertain whether summary of findings table ‐ Starting short‐term prophylactic dose… changes venous thromboembolism compared with avoiding anticoagulation (very low certainty).

1 finding from 1 review

Summary of findings table ‐ Starting short‐term prophylactic dose anticoagulation vs avoiding anticoagulation

Intracerebral haemorrhage (ICH) · survivors of stroke due to intracerebral haemorrhage

It is very uncertain whether summary of findings table ‐ Starting short‐term prophylactic dose… changes intracerebral haemorrhage (ICH) compared with avoiding anticoagulation (very low certainty).

1 finding from 1 review

Summary of findings table ‐ Starting short‐term prophylactic dose anticoagulation vs avoiding anticoagulation

Functional status: mRS 0‐2 · survivors of stroke due to intracerebral haemorrhage

It is very uncertain whether summary of findings table ‐ Starting short‐term prophylactic dose… changes functional status: mRS 0‐2 compared with avoiding anticoagulation (very low certainty).

1 finding from 1 review

Summary of findings table ‐ More time vs less time

Serious adverse events/death: medium‐term outcomes · rehabilitation (medium‐term outcomes)

It is very uncertain whether summary of findings table ‐ More time changes serious adverse events/death: medium‐term outcomes compared with less time (very low certainty).

1 finding from 1 review